Navigation Links
Bird-flu Vaccine Adjuvant Contract Goes to Novartis

Swiss-based global pharmaceutical giant Novartis bagged the contract to make a chemical that would boost the effectiveness of bird-flu vaccines. The $54.8 million contract// was finalised on Wednesday.

The company already has more than $300 million in federal contracts to fight a possible bird-flu outbreak in humans.

Two other firms were also awarded contracts on Wednesday by the U.S. Department of Health and Human Services. GlaxoSmithKline of England got $63.3 million and Iomai of Maryland was given $14.4 million.

The government expects the companies to intensify bird-flu vaccines by employing adjuvants. These increase the body's immune response thereby reducing quantity of vaccine required for protection.

'A vaccine that uses adjuvant could provide a way to extend a limited vaccine supply to more people,' said Health and Human Services Secretary Mike Leavitt said in a statement.

Chicken egg technique is the conventional method of making vaccines but experts find the cell-culture method is faster in producing large quantities of bird-flu vaccine. Novartis received $220.5 million in May, from federal officials to produce a bird-flu vaccine from cell cultures in addition to two other contracts.

'These are all important contracts,' said Novartis spokeswoman Alison Marquiss, 'throwing everything we can at pandemic preparedness.'

Under the contract Novartis will attempt to make a new bird-flu vaccine adjuvant with slight changes in the existing seasonal-flu adjuvant, named MF59. MF59 was developed by Chiron from water and shark liver oil, and is used by older people who need to boost their immune systems.

Health experts opine that two doses of a vaccine might be required to protect someone against H5N1, with 90 micrograms of the antigen in each dose. The dosage of adjuvant required is still not clear.
PRI
'"/>




Page: 1

Related medicine news :

1. H5N1 Bird-flu Confirmed in France
2. Hungry for respite: Bird-flu virus ruffles poultry in Hungary
3. Intelligent Ways to Prevent a Bird-flu Outbreak
4. Daronrix, Glaxos Bird-flu Vaccine Approved by European Medicines Agency
5. Thai’s Health Ministry Stocked To Deal With Any Possible Bird-flu Outbrea
6. Vaccine to quit smoking?
7. First Vaccine Designed for Africa Cleared for Testing in Humans
8. Vaccine for Alzheimer’s diseas
9. Health Officials Recommend Flu Vaccine
10. Smallpox Vaccine May Help Fight Cervical Cancer
11. Panacea Biotech To Market Anthrax Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... N.J. (PRWEB) , ... June 27, 2016 , ... Quality ... sources, yet in many ways they remain in the eye of the beholder, according ... (EBO), a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a weight ... app plans to fix the two major problems leading the fitness industry today:, ... program , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
Breaking Medicine Technology: